Average Co-Inventor Count = 3.27
ph-index = 22
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Translate Bio, Inc. (127 from 150 patents)
2. Transkaryotic Therapies, Inc. (26 from 40 patents)
3. Shire Human Genetic Therapies, Inc. (13 from 85 patents)
4. Ethris Gmbh (5 from 22 patents)
5. Massachusetts Institute of Technology (4 from 8,321 patents)
6. Rana Therapeutics, Inc. (3 from 4 patents)
7. Other (2 from 832,347 patents)
8. Takeda Pharmaceutical Company Limited (1 from 1,161 patents)
9. Synageva Biopharma Corporation (1 from 25 patents)
173 patents:
1. 12421538 - Quantitative assessment for cap efficiency of messenger RNA
2. 12410422 - Methods for purification of messenger RNA
3. 12377053 - Cationic polymers
4. 12370238 - Composition and methods for treatment of primary ciliary dyskinesia
5. 12370262 - Messenger RNA vaccines and uses thereof
6. 12331005 - Ionizable cationic lipids
7. 12280117 - Lipid nanoparticle formulations for delivery of MRNA
8. 12280147 - PEG lipidoid compounds
9. 12268754 - Composition and methods for treatment of ornithine transcarbamylase deficiency
10. 12247046 - Ribonucleic acids with 4'-thio-modified nucleotides and related methods
11. 12240824 - Vitamin cationic lipids
12. 12234446 - Methods for purification of messenger RNA
13. 12201677 - Messenger RNA therapy for the treatment of ornithine transcarbamylase deficiency
14. 12195505 - Treatment of cystic fibrosis by delivery of nebulized mRNA encoding CFTR
15. 12144871 - Stable compositions of MRNA-loaded lipid nanoparticles and processes of making